What's breaking now, across thousands of outlets.
Dietary arginine reduces tumor formation and viral load in mice by boosting key immune proteins.
We haven't written up this one. Science News has the full story — the link below goes straight to it.
[UCT] Asymptomatic tuberculosis (TB) is common and biologically more complex than previously understood, with implications for treatment and care strategies.
[IPS] United Nations -- The Democratic Republic of Congo (DRC) is battling the fastest-growing Ebola outbreak on record, with United Nations officials warning that hunger is actively undermining…
Included Health’s deal to acquire Firefly Health is a big bet on the future of alternative health plans. Alternative plans aren't your traditional broad-network PPO, narrower HMO or high deductible…
Biopharma earnings season is also pipeline update season. On Thursday, Takeda, Regeneron, Sanofi and Bristol Myers Squibb all announced program cuts as part of their quarterly updates.
More details have emerged about how the industry’s largest psychedelic biotech buyout came to fruition. In an SEC filing on Thursday morning, AtaiBeckley disclosed some of the play-by-play from its
Pfizer reports Phase 3 wins for Litfulo: The drug succeeded in two trials for active and stable nonsegmental vitiligo, an autoimmune condition that causes skin to progressively lose its color. One ...